| Literature DB >> 34568765 |
Sarah Cuschieri1, Stephan Grech2.
Abstract
People suffering from non-communicable diseases (NCDs) are at an increased risk for severe Covid-19. The aim was to determine the burden of common NCDs at a population level, assess Covid-19 impact while exploring whether a syndemic approach is merited to deal with NCDs and Covid-19. Baseline data from a Malta national representative survey. Individuals with type 2 diabetes (T2DM), hypertension, cardiovascular disease, dyslipidaemia and overweight-obese status were considered. Prevalence for single disease and multimorbidity were used to estimate population burden. Covid-19 impact at a population level was estimated through local Covid-19 infectivity rates. Years of life lost (YLL) and mortality rate were calculated using Covid-19 data and compared to corresponding NCDs data reported by global burden of disease (GBD) study. Half the study population (n = 3947) had a single NCD while a third had multimorbidity. Of these, 6.55% were estimated to be at risk of Covid-19 and require admission. Covid-19 YLL over 12 months was 5228.54 years, which is higher than the estimated YLL for hypertension and T2DM by GBD study for Malta. Health systems and policies should be re-focused to accommodate both Covid-19 and NCDs simultaneously through a targeted syndemic approach with primary healthcare playing a central role. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s42399-021-01064-2.Entities:
Keywords: Coronavirus; Malta; Multimorbidity; Non communicable diseases; Syndemic
Year: 2021 PMID: 34568765 PMCID: PMC8455231 DOI: 10.1007/s42399-021-01064-2
Source DB: PubMed Journal: SN Compr Clin Med ISSN: 2523-8973
Fig. 1Distribution of common NCDs as single diseases and multimorbidity among the study population stratified by gender
Distribution of the NCDs burden at a population level by age groups and gender
| Single disease | Multimorbidity | ||||||
|---|---|---|---|---|---|---|---|
| Age groups | T2DM | Overweight BMI | Obese BMI | Dyslipidaemia | CVD | ||
| Female | < = 19 | 0 | 797 | 399 | 0 | 0 | 0 |
| 20–24 | 0 | 2299 | 1690 | 270 | 0 | 947 | |
| 25–29 | 463 | 3522 | 3336 | 1112 | 0 | 1112 | |
| 30–34 | 0 | 4748 | 2724 | 0 | 234 | 1168 | |
| 35–39 | 0 | 3873 | 2641 | 176 | 0 | 1496 | |
| 40–44 | 269 | 4301 | 1792 | 448 | 90 | 1882 | |
| 45–49 | 0 | 3967 | 2550 | 567 | 71 | 2975 | |
| 50–54 | 258 | 3288 | 2450 | 967 | 0 | 3933 | |
| 55–59 | 79 | 3228 | 2598 | 1024 | 0 | 7795 | |
| 60–64 | 0 | 2197 | 2727 | 530 | 0 | 8106 | |
| 65–69 | 327 | 2535 | 1963 | 2045 | 0 | 9242 | |
| 70 | 0 | 119 | 317 | 198 | 79 | 1505 | |
| Male | < = 19 | 0 | 0 | 2,113 | 0 | 0 | 423 |
| 20–24 | 0 | 2434 | 504 | 420 | 0 | 1595 | |
| 25–29 | 0 | 5503 | 2935 | 0 | 0 | 4311 | |
| 30–34 | 0 | 6526 | 4213 | 1404 | 0 | 1900 | |
| 35–39 | 181 | 5421 | 3975 | 1175 | 0 | 4427 | |
| 40–44 | 72 | 5040 | 4176 | 1656 | 0 | 4464 | |
| 45–49 | 588 | 4285 | 2100 | 1008 | 0 | 4705 | |
| 50–54 | 440 | 2493 | 2859 | 1100 | 220 | 6818 | |
| 55–59 | 556 | 4102 | 1391 | 1877 | 0 | 8343 | |
| 60–64 | 398 | 2229 | 876 | 1592 | 0 | 9872 | |
| 65–69 | 907 | 2266 | 1662 | 1738 | 378 | 9519 | |
| 70 | 142 | 213 | 0 | 320 | 71 | 1385 | |
| Total | 4680 | 75,387 | 51,992 | 19,626 | 1142 | 97,922 | |
*CVD represented a history for either myocardial infarction or coronary heart disease
Estimated Maltese population at risk of Covid-19 infection and requiring admission to hospital among NCD population
| Diabetes | CVD | Multimorbidity | Total | |
|---|---|---|---|---|
| Population* ( | 4680 | 1142 | 97,922 | |
| COVID-19 admission rate | 12.40% | 14.60% | 20.20% | |
| Population at risk | 580 | 167 | 19,780 | 20,527 |
*Population between 18 and 70 years
Total Maltese population between 18 and 70 years is 313,166
Comparisons between mortality per 100,000 and years of life lost (YLLs) of Covid-19, cardiovascular disease, hypertension, and type 2 diabetes
| Mortality causes | Mortality per 100,000 | YLLs |
|---|---|---|
| COVID-19 | 64.33 | 5228.54 |
| Cardiovascular disease | 209.45 | 12,998.26 |
| Hypertension | 11.74 | 623.23 |
| Type 2 diabetes | 27.14 | 1776.37 |
YLLs, Years of Life Lost (over a year)
Mortality per 100,000 and YLLs based on Global Burden of Disease Study 2019 (excl. COVID-19)